Advertisement

Topics

CRISPR Therapeutics and Neon Therapeutics Enter Research Collaboration

06:50 EDT 17 Jul 2017 | Synbiobeta

CAMBRIDGE, Mass. and BASEL, Switzerland, July 10, 2017 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, and Neon Therapeutics, an immuno-oncology company developing neoantigen-based therapeutic vaccines and T cell therapies to treat […]

The post CRISPR Therapeutics and Neon Therapeutics Enter Research Collaboration appeared first on SynBioBeta.

Original Article: CRISPR Therapeutics and Neon Therapeutics Enter Research Collaboration

NEXT ARTICLE

More From BioPortfolio on "CRISPR Therapeutics and Neon Therapeutics Enter Research Collaboration"

Quick Search
Advertisement